4b3c: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='4b3c' size='340' side='right'caption='[[4b3c]], [[Resolution|resolution]] 1.90Å' scene=''> | <StructureSection load='4b3c' size='340' side='right'caption='[[4b3c]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4b3c]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[4b3c]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Pyrococcus_furiosus Pyrococcus furiosus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4B3C OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4B3C FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5H1:1H-INDOL-5-OL'>5H1</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4b3c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4b3c OCA], [https://pdbe.org/4b3c PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4b3c RCSB], [https://www.ebi.ac.uk/pdbsum/4b3c PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4b3c ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4b3c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4b3c OCA], [https://pdbe.org/4b3c PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4b3c RCSB], [https://www.ebi.ac.uk/pdbsum/4b3c PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4b3c ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[https://www.uniprot.org/uniprot/RADA_PYRFU RADA_PYRFU] Involved in DNA repair and in homologous recombination. Binds and assemble on single-stranded DNA to form a nucleoprotein filament. Hydrolyzes ATP in a ssDNA-dependent manner and promotes DNA strand exchange between homologous DNA molecules. | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 26: | Line 26: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Abell | [[Category: Pyrococcus furiosus]] | ||
[[Category: Blundell | [[Category: Abell C]] | ||
[[Category: Ehebauer | [[Category: Blundell TL]] | ||
[[Category: Hyvonen | [[Category: Ehebauer MT]] | ||
[[Category: Marsh | [[Category: Hyvonen M]] | ||
[[Category: Pukala | [[Category: Marsh M]] | ||
[[Category: Scott | [[Category: Pukala T]] | ||
[[Category: Venkitaraman | [[Category: Scott DE]] | ||
[[Category: Venkitaraman AR]] | |||
Latest revision as of 14:42, 20 December 2023
Humanised monomeric RadA in complex with 5-hydroxy indoleHumanised monomeric RadA in complex with 5-hydroxy indole
Structural highlights
FunctionRADA_PYRFU Involved in DNA repair and in homologous recombination. Binds and assemble on single-stranded DNA to form a nucleoprotein filament. Hydrolyzes ATP in a ssDNA-dependent manner and promotes DNA strand exchange between homologous DNA molecules. Publication Abstract from PubMedThe ability to identify inhibitors of protein-protein interactions represents a major challenge in modern drug discovery and in the development of tools for chemical biology. In recent years, fragment-based approaches have emerged as a new methodology in drug discovery; however, few examples of small molecules that are active against chemotherapeutic targets have been published. Herein, we describe the fragment-based approach of targeting the interaction between the tumour suppressor BRCA2 and the recombination enzyme RAD51; it makes use of a screening pipeline of biophysical techniques that we expect to be more generally applicable to similar targets. Disruption of this interaction in vivo is hypothesised to give rise to cellular hypersensitivity to radiation and genotoxic drugs. We have used protein engineering to create a monomeric form of RAD51 by humanising a thermostable archaeal orthologue, RadA, and used this protein for fragment screening. The initial fragment hits were thoroughly validated biophysically by isothermal titration calorimetry (ITC) and NMR techniques and observed by X-ray crystallography to bind in a shallow surface pocket that is occupied in the native complex by the side chain of a phenylalanine from the conserved FxxA interaction motif found in BRCA2. This represents the first report of fragments or any small molecule binding at this protein-protein interaction site. Using a Fragment-Based Approach To Target Protein-Protein Interactions.,Scott DE, Ehebauer MT, Pukala T, Marsh M, Blundell TL, Venkitaraman AR, Abell C, Hyvonen M Chembiochem. 2013 Jan 23. doi: 10.1002/cbic.201200521. PMID:23344974[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||